Description

2-(2,6-Difluorophenyl)-3,5-Dioxo-2,3,4,5-Tetrahydro-1,2,4-Triazine-6-Carbonitrile is a high-purity, advanced pharmaceutical intermediate characterized by its unique difluorophenyl-substituted triazine-carbonitrile structure. This compound is a critical building block in modern medicinal chemistry, enabling the synthesis of novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily utilized by R&D laboratories and production facilities in the pharmaceutical and agrochemical sectors for the development of next-generation products.

Application

• Pharmaceutical Intermediate: A key synthon for the research and commercial synthesis of novel drug candidates, particularly in therapeutic areas requiring fluorinated heterocycles.
• Agrochemical Research: Serves as a precursor in the development of new herbicides, fungicides, and insecticides, leveraging the biological activity of the triazine core.
• Chemical Synthesis Building Block: Used in organic synthesis to construct complex molecular architectures for material science and specialty chemical applications.
• R&D Reference Standard: Employed as a high-purity analytical standard in method development and quality control within analytical laboratories.

Basic Information

Product Name	2-(2,6-Difluorophenyl)-3,5-Dioxo-2,3,4,5-Tetrahydro-1,2,4-Triazine-6-Carbonitrile
CAS No.	338982-41-5
Molecular Formula	C₁₀H₄F₂N₄O₂
Molecular Weight	250.16 g/mol
Synonyms	6-Cyano-2-(2,6-difluorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione; 2-(2,6-Difluorophenyl)-6-cyano-1,2,4-triazine-3,5(2H,4H)-dione; 338982-41-5; 2,6-Difluorophenyl triazine carbonitrile; Triazine-6-carbonitrile, 2-(2,6-difluorophenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-; 1,2,4-Triazine-6-carbonitrile, 2-(2,6-difluorophenyl)-3,5-dioxo-2,3,4,5-tetrahydro-
EINECS	Contact for details

Quality Control

Our 2-(2,6-Difluorophenyl)-3,5-Dioxo-2,3,4,5-Tetrahydro-1,2,4-Triazine-6-Carbonitrile is manufactured under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical intermediate applications. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider inert gas purging to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.